Clinical Trial Update: Maraviroc Efficacy for Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing maraviroc for hepatitis C in HIV-infected individuals; the study has completed and results were posted on May 1, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Selzentry (Maraviroc) (Maraviroc)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Hepatitis C, Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED | Results posted: 2024-05-01